<DOC>
	<DOC>NCT01992458</DOC>
	<brief_summary>The indication of implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death has been introduced later in France than in other parts of the World. Overall, we aimed to assess the risk-benefit ratio of this strategy over a 10 year period.</brief_summary>
	<brief_title>Primary Prevention ICD French Registry</brief_title>
	<detailed_description />
	<criteria>Coronary artery disease or dilated cardiomyopathy with low ejection fraction implanted with an ICD in the setting of primary prevention (criteria at the discretion of the physician) Setting of secondary prevention Other cardiopathies such as congenital, channelopathies, valvulopathies</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>implantable cardioverter defibrillator</keyword>
	<keyword>death</keyword>
	<keyword>shock</keyword>
	<keyword>mortality</keyword>
	<keyword>complication</keyword>
	<keyword>sudden death</keyword>
</DOC>